Invenomic Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-166,714
| Closed | -$3.69M | – | 167 |
|
|
2024
Q1 | $3.69M | Sell |
166,714
-5,098
| -3% | -$113K | 0.2% | 110 |
|
|
2023
Q4 | $3.71M | Sell |
171,812
-114,145
| -40% | -$2.46M | 0.17% | 115 |
|
|
2023
Q3 | $4.83M | Buy |
285,957
+7,139
| +3% | +$121K | 0.2% | 96 |
|
|
2023
Q2 | $3.83M | Buy |
278,818
+191,566
| +220% | +$2.63M | 0.19% | 92 |
|
|
2023
Q1 | $1.98M | Buy |
+87,252
| New | +$1.98M | 0.11% | 122 |
|